Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension (NCT07090161)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
🩺 Plain-English Summary (8th-Grade Level)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension
Who can join: Review the eligibility criteria below.
Location: Vanda Investigative Site — Phoenix, Arizona
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (28 Sites)
Showing the first 25 of 28 sites.
- Vanda Investigative Site — Phoenix, Arizona
- Vanda Investigative Site — Tempe, Arizona
- Vanda Investigative Site — Tucson, Arizona
- Vanda Investigative Site — Chula Vista, California
- Vanda Investigative Site — Dublin, California
- Vanda Investigative Site — Valencia, California
- Vanda Investigative Site — Walnut Creek, California
- Vanda Investigative Site — Doral, Florida
- Vanda Investigative Site — Fort Myers, Florida
- Vanda Investigative Site — Columbus, Georgia
- Vanda Investigative Site — Oak Brook, Illinois
- Vanda Investigative Site — Tinley Park, Illinois
- Vanda Investigative Site — El Dorado, Kansas
- Vanda Investigative Site — Wichita, Kansas
- Vanda Investigative Site — Lexington, Kentucky
- Vanda Investigative Site — Hazelwood, Missouri
- Vanda Investigative Site — Las Vegas, Nevada
- Vanda Investigative Site — Mount Kisco, New York
- Vanda Investigative Site — Rochester, New York
- Vanda Investigative Site — Kinston, North Carolina
- Vanda Investigative Site — Cincinnati, Ohio
- Vanda Investigative Site — Norman, Oklahoma
- Vanda Investigative Site — Oklahoma City, Oklahoma
- Vanda Investigative Site — Charleston, South Carolina
- Vanda Investigative Site — Carrollton, Texas
📞 Contact the Study Coordinator
Phone: (202) 734-3400
Email: clinicaltrials@vandapharma.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hypertension
- Implementing a Home Blood Pressure Monitoring Program in Primary Care — New York, New York
- SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Birmingham, Alabama
- Stress and Blood Pressure Management for Caregivers — Columbus, Ohio
- Caveolin-1 and Vascular Dysfunction — Boston, Massachusetts
- The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension — Birmingham, Alabama
- Skills-Based Educational Strategies for Reduction of Vascular Events in Orange County — Irvine, California
Explore by condition: All Hypertension clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.